Control of Childhood Congenital Adrenal Hyperplasia and Sleep Activity and Quality with Morning or Evening Glucocorticoid Therapy
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
CONTEXT: Traditionally, hydrocortisone (HC) replacement therapy in congenital adrenal hyperplasia (CAH) is given by three daily doses, albeit not necessarily of equal quantity. Although a higher dose in the morning better imitates the physiological diurnal variation, a late-night higher dose was suggested to better suppress early morning hypothalamic-pituitary-adrenal axis peak activity. Yet, increased night cortisol has been claimed to be associated with sleep disturbances and insomnia. OBJECTIVE: Our objective was to evaluate evening vs. morning high-HC dose with respect to disease control, sleep pattern, and daytime activity in children with CAH. DESIGN: An open-label, cross-over, randomized trial of 15 children with classical CAH was performed. Patients were randomized to receive 50% of the daily HC in the morning or evening for 2 wk; the other two doses included 25% of the daily dose each. OUTCOME MEASURES: Disease control was assessed by 0800-h 17-hydroxyprogesterone, testosterone, androstenedione, and dehydroepiandrosterone sulfate on the last day of each treatment schedule. Sleep and daytime activity were assessed by a 7-d actigraph. RESULTS: Basal morning androstenedione, 17-hydroxyprogesterone, dehydroepiandrosterone sulfate, and testosterone levels during the high-morning and high-evening HC treatment schedules were comparable. There were no significant differences in sleep or daytime activity. CONCLUSIONS: With respect to disease control, sleep quality and daytime activity were not affected by treatment schedules. We recommend the high-morning dose schedule in replacement therapy of children with CAH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A phase III trial including 122 patients with classic CAH revealed superior hormonal control during the early morning and early afternoon compared to patients receiving standard glucocorticoid therapy (338,385).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [338]
In the citing paper
“Insufficient data exist to recommend fractional distribution of doses throughout the day or empiric dosing in the very early morning hours (195).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [195]
Citations
Cites
Buckley, T. M., & Schatzberg, A. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1056 · Cited by 964
Acebo, C., Sadeh, A., Seifer, R., Tzischinsky, O., Wolfson, A. R., Hafer, A., & Carskadon, M. A. (1999) · Sleep · doi:10.1093/sleep/22.1.95 · Cited by 721
Vgontzas, A. N., & Chrousos, G. P. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00005-6 · Cited by 414
Sadeh, A., Lavie, P., Scher, A., Tirosh, E., & Epstein, R. (1991) · PEDIATRICS · doi:10.1542/peds.87.4.494 · Cited by 335
A Novel Adaptive Wrist Actigraphy Algorithm for Sleep-Wake Assessment in Sleep Apnea Patients
Hedner, J., Pillar, G., Pittman, S. D., Zou, D., Grote, L., & White, D. P. (2004) · Sleep · doi:10.1093/sleep/27.8.1560 · Cited by 214
Self-citationActigraphy in the Assessment of Insomnia
Vallières, A., & Morin, C. M. (2003) · Sleep · doi:10.1093/sleep/26.7.902 · Cited by 194
Nocturnal Cortisol Release in Relation to Sleep Structure
Follenius, M., Brandenberger, G., Bandesapt, J. J., Libert, J. P., & Ehrhart, J. (1992) · Sleep · doi:10.1093/sleep/15.1.21 · Cited by 185
Endocrine withdrawal syndromes
Hochberg, Z., Pacak, K., & Chrousos, G. P. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0014 · Cited by 181
Self-citationSide effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial
Chrousos, G. A. (1993) · JAMA · doi:10.1001/jama.269.16.2110 · Cited by 170
Charmandari, E., Johnston, A., Brook, C., & Hindmarsh, P. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690065 · Cited by 104
Research works printed but not linked: 2
- Diamond, 2004, Normative laboratory results, In: Pescovitz OH, Eugster EA, eds. Pediatric endocrinology: mechanisms, manifestations, and management. Philadelphia: Lippincott Williams & Wilkins;, 780
- Etzioni T, 2007, Sleep disordered breathing events are associated with autonomic activations in children with OSA, Sleep, 30, A68
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“tribution of doses throughout the day or empiric dosing in the very early morning hours (195).”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Use of actigraphy for assessment in pediatric sleep research
Meltzer, L. J., Montgomery-Downs, H. E., Insana, S. P., & Walsh, C. M. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.10.002 · Cited by 628
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
“A total of 10 to 17 mg/m(2) daily divided in 2 to 3 doses is typically recommended,(29) although it remains unclear if a specific dose distribution throughout the day has a significant clinical impact.(102) The lowest possible dose should be used to avoid growth suppression.”
BackgroundManagement of adolescents with congenital adrenal hyperplasia
Merke, D. P., & Poppas, D. P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70138-4 · Cited by 134
Verma, S., VanRyzin, C., Sinaii, N., Kim, M. S., Nieman, L. K., Ravindran, S., Calis, K. A., Arlt, W., Ross, R. J., & Merke, D. P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03636.x · Cited by 126
Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Reisch, N., Arlt, W., & Krone, N. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327794 · Cited by 106
“A short-term study in 15 children comparing both treatment regimens (high morning vs. high evening hydrocortisone dose) did neither show differences in hormonal control nor sleep quality [”
BackgroundTreatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102
Webb, E. A., & Krone, N. P. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.002 · Cited by 72
“replacement regime with a high-morning dose rather t an a reverse circadian rhythm (44)”
BackgroundGlucocorticoid replacement regimens for treating congenital adrenal hyperplasia
Ng, S. M., Stępień, K. M., & Krishan, A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012517.pub2 · Cited by 58
“The remaining three trials did not report blinding of investigators or participants (Caldato 2004; German 2008; Nebesio 2016).”
BackgroundMethodInfluentialCongenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 44
“HC is often administered three times a day, and there is no clear advantage of increasing the dose in the morning or evening (95).”
BackgroundClinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 37
“No clear benefit has been identified with increasing morning or evening doses (94).”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 37
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 35
Male pseudohermaphroditism as a cause of secondary hypertension: a case report
Aydın, Z., Öztürk, S., Gürsu, M., Uzun, S., Karadağ, S., & Kazancıoğlu, R. (2010) · Endocrine · doi:10.1007/s12020-010-9357-x · Cited by 33
“Usually, hypertension resolves with glucocorticoid therapy [9, 10] but it may persist if the diagnosis is delayed.”
BackgroundRussian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Bacila, I. A., Lawrence, N., Mahdi, S., Alvi, S., Cheetham, T. D., Crowne, E. C., Das, U., Dattani, M., Davies, J. H., Gevers, E. F., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1109 · Cited by 24
“Evidence comparing the benefits of circadian and reverse circadian administration regimes has so far been inconclusive in CAH (31); however, in adrenal insufficiency, evening elevation of plasma cortisol was associated with an increased risk of metabolic complications (32).”
Substitution therapy in adult patients with congenital adrenal hyperplasia
Reisch, N. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.11.002 · Cited by 24
Schröder, M. A. M., van Herwaarden, A. E., Span, P. N., van den Akker, E. L. T., Bocca, G., Hannema, S. E., van der Kamp, H. J., Kort, S. W. K. D., Mooij, C. F., Schott, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab826 · Cited by 22
Ajish, T., Pavithran, P. V., Nisha, B., & Kumar, H. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.141358 · Cited by 13
“Conclusions: There is no significant advantage in administering the hydrocortisone dose late at night in patients with classical CAH.”
BackgroundInfluentialDauber, A. N., Feldman, H. A., & Majzoub, J. A. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/347636 · Cited by 12
“[30] that showed no difference in disease control as assessed by 08:00 hormonal levels in subjects receiving a higher dose of hydrocortisone in the evening versus the morning.”
BackgroundKendırcı, H. N. P., Ünal, E., Dündar, İ., Buluş, A. D., Güneş, S. O., & Şıklar, Z. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-26-s · Cited by 11
“There is insufficient data regarding the administration of HC doses predominantly in the morning or evening hours (21,22).”
Medical treatment of classic and nonclassic congenital adrenal hyperplasia
Speiser, P. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8002-1_9 · Cited by 10
“There are scant data to recommend administering a higher dose of HC in either morning or evening [5].”
BackgroundDubinski, I., Dalla-Pozza, S. B., Bidlingmaier, M., Reisch, N., & Schmidt, H. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0540 · Cited by 10
Matallana-Rhoades, A. M., Corredor-Castro, J. D., Mecias-Cruz, B. V., Bonilla-Escobar, F. J., & de Beldjenna, L. M. (2016) · Colombia medica · doi:10.25100/cm.v47i3.1722 · Cited by 10
Dubinski, I., Bechtold, S. M., Bidlingmaier, M., Reisch, N., & Schmidt, H. (2022) · Hormone Research in Paediatrics · doi:10.1159/000526485 · Cited by 8
Apsan, J., Thomas, C., Elnaas, H., Lin‐Su, K., & Lekarev, O. (2022) · Hormone Research in Paediatrics · doi:10.1159/000523808 · Cited by 4
Bethin, K. E., & Muglia, L. J. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_12 · Cited by 4
Congenital adrenal hyperplasia in children – a survey on the current practice in the UK
Niranjan, U., & Natarajan, A. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0362 · Cited by 4
“J Pediatr Endocr Met 2015; 28(7-8): 847–851”
Nowotny, H. F., Choi, H., Ziegler, S., Doll, N., Bäuerle, A., Welp, A.-C., Dubinski, I., Schiergens, K. A., Neumann, U., Tschaidse, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041479 · Cited by 3
“Randomized trials comparing high-morning versus high-evening HC dosing in children with classical CAH have shown similar levels of morning androgen markers, sleep quality, and daytime activity between regimens, favoring the traditional high-morning dose approach [10,11].”
Cao, Y., Yang, S., Yili, J., Tuersun, N., Wang, Z., Cai, X., Rong, L., & Wu, T. (2019) · Springer eBooks · doi:10.1007/978-981-15-0591-1_18 · Cited by 3
Wójcik, M. (2013) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.s12-005 · Cited by 3
Thomson, M. (2010) · Current Signal Transduction Therapy · doi:10.2174/157436210791112181 · Cited by 2
“The condition can be lifethreatening and is usually treated by corticosteroid replacement therapy [48].”
BackgroundLevshtein, A., Sharkia, M., Shimshi-Barash, M., Almagor, T., Albertsson-Wikland, K. G., Hochberg, Z., Pillar, G., & German, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1483199 · Cited by 2
“This technique is essential for examining sleep-wake cycles and circadian rhythms, aiding in the evaluation of daytime sleepiness, and enabling long-term tracking of sleep patterns within a home setting across various groups, such as infants, children, and adolescents (25, 26, 39).”
Self-citationBethin, K. E., Majumdar, I., & Muglia, L. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_13 · Cited by 2
Hydrocortisone Replacement in Disorders of Sex Development
Blankenstein, O. (2014) · Endocrine development · doi:10.1159/000363752 · Cited by 2
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_59 · Cited by 2
Bethin, K. E., Majumdar, I., & Muglia, L. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_10 · Cited by 2
Golob, L., Munoz, Y. M., Liu, W., Singh, A., Hodges, J. S., Siegel, L. K., Morero, H., Gao, Z., Tipp, A., Simon, S. L., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae836 · Cited by 1
“Only 2 previous studies of children with CAH reported on sleep health (19, 20).”
Het fysiek, sociaal en maatschappelijk functioneren van kinderen met AGS en hun ouders.
Sanches, S. A., & Wiegers, T. A. (2010) · Data Archiving and Networked Services (DANS) · Cited by 1
Hypokalaemic paralysis in a 15-year-old boy with 11β-hydroxylase deficiency
Rustagi, V. T., Khadilkar, V. V., & Khadilkar, A. V. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.186 · Cited by 1
“His weakness completely recovered in the next 48 h and he was discharged on oral hydrocortisone (10 mg/m 2 /day) (3).”
BackgroundCongenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-1 · Cited by 1
Inherited Metabolic Disorders: A Current Status
Shahid, M., Rasool, A., & Anjum, F. (2020) · Emerging contaminants and associated treatment technologies · doi:10.1007/978-3-030-45923-9_4 · Cited by 1
Hindmarsh, P. C., & Geertsma, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811483-4.00015-5
POSSIBILITIES AND THERAPY LIMITATIONS IN A CASE OF ADRENOGENITAL SYNDROME
Grama, A., Marginean, O. C., Popa, L., Meliţ, L. E., Latcu, A., & Chinceşan, M. I. (2016) · Romanian Journal of Pediatrics · doi:10.37897/rjp.2016.2.10
Berberoğlu, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_3
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_59
Gec Tani Almis Komplet Virilize bir 46,XX 11-Beta Hidroksilaz Eksikligi Olgusu
Emeksiz, H. C., Altın, H., & Çitli, Ş. (2016) · Gazi Medical Journal · doi:10.12996/gmj.2016.54
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-2
Sleep, Mood and Cognitive Affects
Hindmarsh, P. C., & Geertsma, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824548-4.00033-4
Brain structure and function in primary adrenal insufficiency
Westeinde, A. V. (2023) · Open Archive (Karolinska Institutet)
Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia
Goai, W. H., & Torpy, D. J. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2695099
“In a trial of 15 children comparing two thrice-daily hydrocortisone schedules—one with a morning-heavy dose and one with an evening-heavy dose—no significant difference were observed in basal morning levels of 17OHP, dehydroepiandrosterone-sulfate (DHEAS), A4, or testosterone after 4 weeks [12].”
Metadata
- Authors
- German, A., Suraiya, S., Tenenbaum-Rakover, Y., Koren, I., Pillar, G., & Hochberg, Z.
- Affiliations
- Rambam Health Care Campus (IL)
- Ha’Emek Medical Center (Y.T.-R.), Afula 18101, Israel
- Clalit Health Services (IL)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Hochberg, Ze'ev
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-12-01
- Volume
- 93
- Issue
- 12
- Pages
- 4707-4710
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2124353228
- Cited by
- 57
- References
- 16
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- congenital adrenal hyperplasia, hydrocortisone replacement, sleep quality, diurnal activity, hypothalamic-pituitary-adrenal axis, 17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone sulfate, testosterone, children
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Arousal, Child, Double-Blind Method, Female, Glucocorticoids, Humans, Sleep Initiation and Maintenance Disorders, Male, Motor Activity, Gonadal Steroid Hormones, Sleep, Time Factors, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.